Anthera Pharmaceuticals Inc Stock Nasdaq
Equities
US03674U2015
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index | CI |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index | CI |
Financials (USD)
Sales 2016 | 0.14 | Sales 2017 | - | Capitalization | 22.85M |
---|---|---|---|---|---|
Net income 2016 | -55M | Net income 2017 | -26M | EV / Sales 2016 | 44,069,434 x |
Net cash position 2016 | 20.84M | Net cash position 2017 | 2.2M | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.4
x | P/E ratio 2017 |
-0.58
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |